Statement Of Cash Flows [Abstract]
| Concept |
2024-01-01 to 2024-12-31 |
2023-01-01 to 2023-12-31 |
|---|---|---|
| Statement of cash flows [abstract] | ||
| Cash flows from (used in) operating activities [abstract] | ||
| Adjustments for interest expense |
332,000
EUR
|
255,000
EUR
|
| Adjustments for interest income |
93,000
EUR
|
70,000
EUR
|
| Adjustments for deferred tax expense |
61,000
EUR
|
511,000
EUR
|
| Cash flows from (used in) operations before changes in working capital |
3,862
EUR
|
4,396
EUR
|
| Adjustments for decrease (increase) in other assets |
0
EUR
|
743,000
EUR
|
| Adjustments for increase (decrease) in other current liabilities |
202,000
EUR
|
706,000
EUR
|
| Adjustments for increase (decrease) in employee benefit liabilities |
200,000
EUR
|
98,000
EUR
|
| Adjustments for decrease (increase) in loans and advances | — | — |
| Adjustments for decrease (increase) in loans and advances to customers |
-
EUR
|
106,000
EUR
|
| Adjustments for decrease (increase) in biological assets |
177,000
EUR
|
204,000
EUR
|